UNC Department of Obstetrics & Gynecology https://www.med.unc.edu/obgyn Caring for women at every stage of their lives… Tue, 13 Jan 2026 18:08:52 +0000 en-US hourly 1 Redesigning Ultrasound for the Frontlines of Pregnancy Care https://ncinnovation.org/media/redesigning-ultrasound-for-the-frontlines-of-pregnancy-care/#new_tab Tue, 13 Jan 2026 18:08:52 +0000 https://www.med.unc.edu/obgyn/?p=6893 Read more]]> When a clinician has to make decisions about a pregnancy without knowing how far along it truly is, every choice becomes harder — and riskier. Early in his career working in Zambia, Dr. Jeffrey Stringer saw this reality play out every day, as the absence of ultrasound forced providers to care for women with critical information missing. “I saw firsthand how the absence of ultrasound undermined our ability to provide good obstetric care,” he said.

Stringer, now a physician-researcher at the University of North Carolina at Chapel Hill, spent more than a decade working in settings where access to prenatal imaging was limited or nonexistent. Without ultrasound, clinicians were left to estimate gestational age, assess fetal growth, and rule out complications using incomplete information — decisions that shape outcomes for both mothers and babies.

The full scope of the problem became clear through research. While analyzing data from an ongoing clinical trial, Stringer and his team noticed what appeared to be an implausibly high preterm birth rate. The numbers raised immediate concern. After deeper analysis, they realized the issue was not that women were delivering early, but that pregnancies were being dated inaccurately. “We realized the root cause was not that the preterm birth rate was that high,” Stringer explained, “but that it only seemed high because inaccurate gestational dating due to lack of ultrasound.” That single gap in information propagated across nearly every aspect of care.

Modern prenatal medicine depends on timing. Screenings, interventions, and clinical decisions follow a carefully sequenced schedule tied directly to gestational age. “If gestational age is wrong, care is mistimed,” Stringer said, “which directly compromises maternal and fetal outcomes.” Without ultrasound, clinicians are forced to make high-stakes decisions without the clarity that modern care assumes.

]]>
Dr. Friday Saidi elected AOGM President and Contributes to FIGO https://www.med.unc.edu/obgyn/2025/12/19/dr-friday-saidi-elected-aogm-president-and-contributes-to-figo/ Fri, 19 Dec 2025 18:21:53 +0000 https://www.med.unc.edu/obgyn/?p=6852 Read more]]>

Dr. Saidi Friday (far right) with the Stringers at FIGO. Dr. Jeff Stringer (Pictured 2nd) is the Division Director for Global Women’s Health at UNC.

We are proud to share that Dr. Friday Saidi, Research Assistant Professor in our Department, attended the International Federation of Gynecology and Obstetrics (FIGO) Congress in Cape Town as a representative of the Association of Obstetricians & Gynaecologists of Malawi (AOGM), which like ACOG, is a member organization of FIGO.

At FIGO, Dr. Saidi presented a research poster titled: Performance of different sample types for high-risk human papillomavirus testing and genotyping using AmpFire® Assay for detection of high grade cervical intraepithelial neoplasia.
Authors included Dr. Jennifer Tang, Dr. Chibwesha, and Dr. Chinula from our Global Women’s Health Division, alongside collaborators from Malawi (Chagomerana MB, Mkochi T, Msowoya L, Jawadu S, Ndovie M., Smith JS).

In addition to his research contributions, Dr. Saidi achieved a significant leadership milestone: he was elected President of AOGM, following his service as AOGM Treasurer.

Dr. Saidi with Dr. Gladys Gadama, who is the outgoing AOGM President

Dr. Saidi (on the right) with Dr. Gladys Gadama, who is the outgoing AOGM President

Dr. Saidi also plays an important role in shaping global clinical guidance. He is a member of the FIGO Committee on Infections During Pregnancy, having served during the 2023–25 term and recently reselected for the 2025–27 term. During his initial term, he contributed to the publication of the FIGO best practice paper on preventing post–cesarean section sepsis:

Lazzaro A, Karandikar G, Martins ML, Saidi F, Aronoff DM, Amaral E, Boucoiran I, Megh M, Jacobsson B, Ortiz Lizcano EI, Money D, Pasupathy D, Buga E; FIGO Committee on Infections During Pregnancy. Reducing post-cesarean sepsis: Current best practice in prevention and treatment. Int J Gynaecol Obstet. 2025 Nov;171(2):517-527. doi: 10.1002/ijgo.70500.

Congratulations to Dr. Saidi for his outstanding leadership and contributions to advancing women’s health globally.

]]>
Dr. Erin Carey and Team Awarded $140K Grant to Advance Vulvar Film Applicator Technology https://www.med.unc.edu/obgyn/2025/12/19/dr-erin-carey-and-team-awarded-140k-grant-to-advance-vulvar-film-applicator-technology/ Fri, 19 Dec 2025 17:51:01 +0000 https://www.med.unc.edu/obgyn/?p=6849 Read more]]>

CHAPEL HILL, N.C. – Drs. Erin Carey, Shawn Hingtgen, and Elizabeth Geller have secured full funding for their Translational Research Grant proposal from the North Carolina Biotechnology Center. The project, titled “Developing a Vulvar Film Applicator for Precision Drug Delivery in Vestibulodynia,” provides critical support for advancing technology in women’s health. Dr. Erin Carey portrait

The initiative is led by Principal Investigator Dr. Shawn Hingtgen, Professor at the UNC Eshelman School of Pharmacy, with Dr. Elizabeth Geller serving as co-investigator. Dr. Carey, an inventor on the project, contributed to the grant writing and will consult on early implementation efforts.

Dr. Erin Carey is the current Division Director of Minimally Invasive Gynecologic Surgery at the UNC School of Medicine and UNC Health. She has served on the national Fellowship Board of Minimally Invasive Gynecologic Surgery (FMIGS) and the interdisciplinary board of the International Pelvic Pain Society. She is a NIH funded clinical scientist, and her long-term goal is to develop personalized mechanism-based treatment strategies for patients with complex gynecologic conditions.

]]>
UNC Women’s Hospital Earns U.S. News “High Performing Maternity Care” Designation for 5th Year https://www.med.unc.edu/obgyn/2025/12/17/unc-womens-hospital-earns-u-s-news-high-performing-maternity-care-designation-for-5th-year/ Wed, 17 Dec 2025 18:46:39 +0000 https://www.med.unc.edu/obgyn/?p=6839 Read more]]> The NC Women’s Hospital has been named a “High Performing Maternity Care” Hospital by U.S. News & World Report, marking UNC’s fifth year receiving this designation and the third consecutive year earning the top recognition for high-performing maternity care, which began in 2021 and evaluates hospitals that provide labor and delivery services and submit detailed data for analysis.
 
2026 hospital ratings for Maternity and Perinatal Care identifies hospitals that provide high-quality labor & delivery services for uncomplicated pregnancies. U.S. News evaluates how well hospitals perform in childbirth using C-section rates, newborn severe complication rates, routine vaginal birth after cesarean delivery (VBAC) rates, episiotomy rates, best practices to support breast milk feeding, whether a hospital meets federal criteria for “birthing-friendly” practices, and whether a hospital tracked and reported disparities in outcomes. This year, 495 top hospitals for Maternity care have been recognized as High Performing.
 
For more information about the data considered when determining this status, please refer to this link and the US news website
]]>
UNC OB/GYN Faculty Presents at 2025 International HPV Conference https://www.med.unc.edu/obgyn/2025/12/02/unc-ob-gyn-faculty-presented-at-international-hpv-meeting/ Tue, 02 Dec 2025 14:51:47 +0000 https://www.med.unc.edu/obgyn/?p=6824 Read more]]> Chapel Hill, NC – University of North Carolina at Chapel Hill researchers played prominent roles at the 37th Annual Conference of the International Papillomavirus Society (IPVS 2025) in Bangkok, Thailand, demonstrating the university’s leadership in global efforts to prevent cervical cancer and HPV-related diseases.
 

UNC Researchers Showcase Global Cervical Cancer Prevention Efforts at 2025 International Papillomavirus Society Conference

Chemtai Mungo, MD, MPH, FACOG, Assistant Professor of Obstetrics and Gynecology at UNC School of Medicine, was invited as faculty and delivered a well-received presentation on cervical cancer screening during the precongress public health workshop. Dr. Mungo, whose research focuses on secondary prevention of cervical cancer in low-resource settings, also moderated two oral presentation sessions, including one on new HPV treatments and treatment outcomes.
 

“The International Papillomavirus Society conference brings together the world’s leading researchers working to eliminate cervical cancer,” said Dr. Mungo. “It was an honor to represent UNC and share insights on how we can improve screening and treatment access in communities that need it most.”

The conference also highlighted promising results from a National Cancer Institute-funded clinical trial led by UNC researchers. Lisa Rahangdale, MD, MPH, Professor of Obstetrics and Gynecology, and Carla Chibwesha, MD, MSc, Associate Professor of Obstetrics and Gynecology, presented findings from their ACT 2 trial examining intravaginal 5-fluorouracil (5FU) cream following surgical treatment in South African women living with HIV who have cervical precancer.

Dr. Chemtai Mungo presents on presentation on cervical cancer screening

Conducted by Dr. Chibwesha’s team at the University of the Witwatersrand in South Africa,  the ACT 2 trial enrolled 180 women with high-grade cervical precancer who underwent loop electrosurgical excision procedure (LEEP) and were randomized to receive either 5FU or placebo cream over 16 weeks.  Intravaginal 5FU was found to be safe and acceptable to women.   By Week 24, 96% of women in the 5FU group achieved regression  low-grade disease or had no evidence of disease , compared to 82% in the placebo group. The benefit of 5FU for women with positive surgical margin was even more pronounced: 88% of women in the 5FU group achieved regression compared to 60% in the placebo group. Additionally,  among women with HPV16—a high-risk strain that causes most cervical cancers—74% receiving 5FU cleared the virus, compared to 40% in the placebo group.

Dr. Chibwesha noted that the results were particularly meaningful in settings with a high burden of both cervical cancer and HIV, saying, “we designed this study to address the critical gap in treatment options for women living with HIV. The success of our trial—the first trial of its kind in Africa—represents a major advance for the field and we look forward to conducting follow-on studies that could benefit thousands of women in sub-Saharan Africa and beyond.”

“Women living with HIV face significantly higher risks of persistnt HPV infection and progression to cervical cancer, even after treatment,” said Dr. Rahangdale. “Our findings suggest that intravaginal 5FU may offer a valuable adjuvant therapy to improve outcomes for this vulnerable population.”

Two students mentored by Dr. Mungo also presented posters: Jessica Gingles from UNC School of Medicine and Annum Sadan from NYU School of Medicine.

Cervical cancer causes more than 340,000 deaths annually worldwide, disproportionately affecting women in low- and middle-income countries where access to screening and treatment is limited. The IPVS conference is the premier international gathering for advancing HPV and cervical cancer prevention research globally.

Dr. Lisa Rahangdale presents findings from their ACT 2 trial examining intravaginal 5-fluorouracil (5FU) cream following surgical treatment

 

Dr. Chemtai Mungo with her mentee, Annum Sadan from NYU School of Medicine

 

]]>
Dr. Chemtai Mungo named Robert A. Winn Career Development Award Scholar https://www.med.unc.edu/obgyn/2025/12/01/dr-chemtai-mungo-named-robert-a-winn-career-development-award-scholar/ Mon, 01 Dec 2025 15:36:35 +0000 https://www.med.unc.edu/obgyn/?p=6813 Read more]]> CHAPEL HILL, N.C— Chemtai Mungo, MD, MPH, FACOG, an assistant professor in the UNC School of Medicine’s Department of Obstetrics and Gynecology and affiliate faculty at the UNC Lineberger Comprehensive Cancer Center, the Center for AIDS Research and the UNC Institute of Global Health and Infectious Diseases has been selected for the Robert A. Winn Excellence in Clinical Trials: Career Development Award (Winn CDA), a prestigious two-year national program that trains early-career physicians to design and lead community-centered clinical trials.
 
Dr. Meredith Newton portraitThe Winn CDA is part of the Robert A. Winn Diversity in Clinical Trials Award Program , a multi-year, $100M+ public–private initiative established by the Bristol Myers Squibb Foundation with partners including Gilead Sciences, Amgen, Genentech, and the American Association of Cancer Research (AACR). The program’s mission is to increase diversity in clinical trials, transform the clinical research landscape, and ensure that treatments are tested, safe, and effective for all patients—especially those in communities that have historically been excluded from research.
 

Dr. Chemtai Mungo is a physician-scientist whose work focuses on secondary prevention of cervical cancer in low-resource settings, with a particular emphasis on self-administered vaginal therapies for cervical precancer in low- and middle-income countries (LMICs), where shortages of trained surgical providers and structural barriers to care are common. She currently leads NIH-funded clinical research aimed at improving human papillomavirus (HPV) treatment outcomes among women living with HIV in Africa and at understanding how the vaginal microbiome shapes responses to novel therapies.

“Having grown up in Kenya and now caring for patients in North Carolina, I see every day how where you live still determines whether you have access to timely, life-saving care,” Mungo said. “The Winn CDA will help me design clinical trials that are rooted in partnership with communities—whether in Africa or rural counties in the U.S.—so that women at highest risk for cervical cancer can benefit from the very science their needs inspire.”

Cervical cancer remains one of the starkest examples of global inequity: an estimated 85–90% of new cases and deaths occur in LMICs, yet cancer clinical trials enroll few patients in these settings and are often led by investigators in high-income countries, limiting relevance to the populations who bear the greatest burden. In the United States, similar patterns of inequity are evident—recent national data show that cervical cancer incidence is roughly 25% higher and mortality 42% higher in rural counties compared with urban areas, reflecting persistent gaps in screening, diagnosis, and treatment access.

Dr. Chemtai Mungo’s research agenda directly targets these gaps by testing feasible, self-administered treatments that can be delivered closer to home, building clinical trial partnerships with public hospitals and safety-net clinics, and mentoring trainees who are committed to advancing health equity in both LMICs and underserved U.S. communities.

Clinical Trial Training Workshop in New Mexico run by AACR

Clinical Trial Training Workshop in New Mexico run by AACR

]]>
New fellowship addresses ‘critical issue’ of rural maternal care deserts https://www.healio.com/news/womens-health-ob-gyn/20251106/qa-new-fellowship-addresses-critical-issue-of-rural-maternal-care-deserts#new_tab Mon, 10 Nov 2025 15:29:46 +0000 https://www.med.unc.edu/obgyn/?p=6801 Read more]]> The University of North Carolina School of Medicine has launched the nation’s first rural OB/GYN fellowship.

The program will train physicians to offer high-quality care in a rural setting, as well as improve access for women in North Carolina’s maternity care deserts, according to a press release.

“More than half of the women in rural North Carolina live more than 30 minutes away from a birthing hospital. That’s more than twice the distance compared to urban areas in the state,” Kavita Arora, MD, MBE, MS, the director of the UNC Rural Obstetrics and Gynecology Fellowship, said in the release. “Our new OB/GYN fellowship is a big step in the right direction to close that gap.”

The UNC School of Medicine will accept applications for the new fellowship through March 31, 2026.

Healio spoke with Arora to learn about the fellowship, what makes it unique and more.

]]>
Taking Medication Safely While Pregnant https://healthtalk.unchealthcare.org/taking-medication-safely-while-pregnant/#new_tab Thu, 23 Oct 2025 16:23:59 +0000 https://www.med.unc.edu/obgyn/?p=6789 Read more]]> Pregnancy is tough for a lot of reasons, not the least of which is balancing your own medical needs with trying to provide the best environment for your baby.

It’s important to be mindful about what you put in your body because your baby is exposed to everything you consume. But you’re still a human being who may need to take medication for short-term or chronic illnesses.

“When we are pregnant, we naturally want to do what’s best for our child,” says UNC Health maternal-fetal medicine specialist Ebony B. Carter, MD, MPH. “A key part of my role as a high-risk OB-GYN is helping parents understand that maintaining their own health—including managing chronic conditions and addressing medical concerns—is essential to supporting a healthy pregnancy.”

Dr. Carter offers this advice for thinking about medication during pregnancy.

]]>
UNC Midwives Recognized as a 2024 Triple Aim Best Practice https://www.med.unc.edu/obgyn/2025/10/13/unc-midwives-recognized-as-a-2024-triple-aim-best-practice/ Mon, 13 Oct 2025 18:41:33 +0000 https://www.med.unc.edu/obgyn/?p=6774 Read more]]>
 
We’re proud to share that UNC Midwives has been recognized by the American College of Nurse-Midwives (ACNM) as a 2024 Triple Aim Best Practice. This national recognition highlights our team’s exceptional performance in maternity care, aligning with the Institute for Healthcare Improvement’s “Triple Aim” goals: improving patient experience, enhancing population health, and reducing the cost of care.
 
Out of 181 participating practices, only 40 earned this prestigious designation by meeting or exceeding key benchmarks, including:
– Primary Cesarean Birth Rate below 23.9%
– Preterm Birth Rate below 11.4%
– Exclusive Breastfeeding in the First 48 Hours above 81%
– Reporting of fiscal outcomes
 
We’re honored to be recognized for our commitment to clinical excellence, patient-centered care, and better health outcomes for the families we serve.
]]>
Researchers awarded $11.2M grant to close endometrial cancer survival gap https://unclineberger.org/news/researchers-awarded-11-2m-grant-to-close-endometrial-cancer-survival-gap/#new_tab Thu, 09 Oct 2025 17:49:09 +0000 https://www.med.unc.edu/obgyn/?p=6771 Read more]]> More than 69,000 women in the U.S. are expected to be diagnosed with endometrial cancer this year, making it the fourth most common cancer in women, and more than 13,900 are projected to die from it.

Unlike most cancers, both incidence and mortality rates for endometrial cancer are rising. It also represents a significant health disparity, with Black women having a five-year survival rate of 63%, compared with 84% for white women.

To better understand and improve outcomes for people with endometrial cancer, the National Cancer Institute has awarded a five-year, $11.2 million Cancer Health Disparities Specialized Program of Research Excellence (SPORE) in Endometrial Cancer grant to Victoria Bae-Jump, MD, PhD, and Hazel Nichols, PhD, at the University of North Carolina Lineberger Comprehensive Cancer Center.

]]>
UNC Gynecologic Oncology Clinic Honored with FY25 Carolina Care Award https://www.med.unc.edu/obgyn/2025/10/07/unc-gynecologic-oncology-clinic-honored-with-fy25-carolina-care-award/ Tue, 07 Oct 2025 09:00:15 +0000 https://www.med.unc.edu/obgyn/?p=6765 Read more]]>

UNC Gynecologic Oncology has been recognized with a FY25 Carolina Care Award for outstanding patient experience. The clinic was named one of the Top 5 clinics across UNC Health and recognized as one of the most improved in patient experience systemwide.

This award reflects the Gynecologic Oncology team’s continued commitment to delivering compassionate, patient-centered care. Thank you to the patients who share their feedback and help us improve every day.

]]>
GOGM Faculty, Fellows, and Alumni Recognized at SASGOG 2025 https://www.med.unc.edu/obgyn/2025/10/06/gogm-faculty-fellows-and-alumni-recognized-at-sasgog-2025/ Mon, 06 Oct 2025 15:51:09 +0000 https://www.med.unc.edu/obgyn/?p=6759 Read more]]> GOGM at the SASGOG 2025 Annual Meeting

The department of General Obstetrics, Gynecology, and Midwifery faculty, fellows, alumni, and learners contributed across presentations and sessions at the Society of Academic Specialists in Obstetrics and Gynecology (SASGOG) Annual Meeting, held September 11–12, 2025, at the Curtis Denver in Colorado.

Fellowship Alumni

  • Meredith Wise, MD, MSCR – Named SASGOG Green Journal Editorial Fellow

  • Austin Johnson, MD – Awarded Best Paper from a conference presentation

  • Dani Tsevat, MD, MSCR – Presented a poster featuring fellowship research


Faculty

  • Andrea Knittel, MD, PhD – Presented on Research Mentorship

  • Kavita Arora, MD, MBE, MS – Presented on Building the Academic Generalist Workforce


Current Fellows

  • Paige Anderson, MD – Poster presentation

  • Grace Trompeter, MD, MSPH – Poster presentation


Medical Student

  • Reagan Ford (UNC) – Poster presentation

]]>